ASX - By Stock
|
CYP |
Re:
Cyp trading
|
|
$4us
|
104 |
31K |
1 |
20/02/18 |
20/02/18 |
ASX - By Stock
|
104
|
31K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Rumours of Fund interest.....
|
|
$4us
|
32 |
13K |
4 |
18/02/18 |
18/02/18 |
ASX - By Stock
|
32
|
13K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
De-Risked, Undervalued & Significant Upside
|
|
$4us
|
77 |
31K |
1 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
77
|
31K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
De-Risked, Undervalued & Significant Upside
|
|
$4us
|
77 |
31K |
3 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
77
|
31K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
De-Risked, Undervalued & Significant Upside
|
|
$4us
|
77 |
31K |
2 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
77
|
31K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Only the beginning ...
|
|
$4us
|
30 |
10K |
4 |
25/01/18 |
25/01/18 |
ASX - By Stock
|
30
|
10K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cyanta & Celularity Inc Execute MOU
|
|
$4us
|
58 |
18K |
13 |
23/01/18 |
23/01/18 |
ASX - By Stock
|
58
|
18K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
CYP-001 being derisked
|
|
$4us
|
16 |
4.9K |
7 |
02/01/18 |
02/01/18 |
ASX - By Stock
|
16
|
4.9K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Receives $1.3m R&D Tax Incentive Refund
|
|
$4us
|
33 |
8.5K |
2 |
18/12/17 |
18/12/17 |
ASX - By Stock
|
33
|
8.5K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
roll out the news
|
|
$4us
|
300 |
82K |
3 |
08/12/17 |
08/12/17 |
ASX - By Stock
|
300
|
82K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
First Cohort Enrollment Completed in CYP-001 Clinical Trial; Reiterate Buy
|
|
$4us
|
54 |
15K |
3 |
07/12/17 |
07/12/17 |
ASX - By Stock
|
54
|
15K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
First Cohort Enrollment Completed in CYP-001 Clinical Trial; Reiterate Buy
|
|
$4us
|
54 |
15K |
3 |
01/12/17 |
01/12/17 |
ASX - By Stock
|
54
|
15K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Enrolment Completed in 1st Cohort of Cynata Clinical Trial
|
|
$4us
|
135 |
34K |
3 |
15/11/17 |
15/11/17 |
ASX - By Stock
|
135
|
34K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
9 Sept Interview BioInformant Dr Macdonald
|
|
$4us
|
10 |
3.0K |
1 |
18/09/17 |
18/09/17 |
ASX - By Stock
|
10
|
3.0K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Game on ... tips me cap
|
|
$4us
|
114 |
28K |
5 |
15/09/17 |
15/09/17 |
ASX - By Stock
|
114
|
28K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: HC Wainwright & Co Updates Cynata Research Coverage
|
|
$4us
|
56 |
14K |
4 |
12/09/17 |
12/09/17 |
ASX - By Stock
|
56
|
14K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: HC Wainwright & Co Updates Cynata Research Coverage
|
|
$4us
|
56 |
14K |
4 |
11/09/17 |
11/09/17 |
ASX - By Stock
|
56
|
14K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: HC Wainwright & Co Updates Cynata Research Coverage
|
|
$4us
|
56 |
14K |
4 |
11/09/17 |
11/09/17 |
ASX - By Stock
|
56
|
14K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Health Canada Meeting Advances CYP Global Development Plans
|
|
$4us
|
27 |
7.5K |
5 |
11/09/17 |
11/09/17 |
ASX - By Stock
|
27
|
7.5K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Health Canada Meeting Advances CYP Global Development Plans
|
|
$4us
|
27 |
7.5K |
4 |
11/09/17 |
11/09/17 |
ASX - By Stock
|
27
|
7.5K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Nice open, sells pulled, clock ticks
|
|
$4us
|
26 |
6.8K |
8 |
07/09/17 |
07/09/17 |
ASX - By Stock
|
26
|
6.8K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Cynata supporter email
|
|
$4us
|
12 |
2.6K |
6 |
01/09/17 |
01/09/17 |
ASX - By Stock
|
12
|
2.6K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
money
|
|
$4us
|
30 |
8.6K |
0 |
29/08/17 |
29/08/17 |
ASX - By Stock
|
30
|
8.6K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Positive Data from CYP MSCs in 2nd Preclinical Asthma Study
|
|
$4us
|
47 |
10K |
15 |
23/08/17 |
23/08/17 |
ASX - By Stock
|
47
|
10K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Positive Data from CYP MSCs in 2nd Preclinical Asthma Study
|
|
$4us
|
47 |
10K |
4 |
23/08/17 |
23/08/17 |
ASX - By Stock
|
47
|
10K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Introducing Cynata - independent research coverage
|
|
$4us
|
60 |
15K |
0 |
16/08/17 |
16/08/17 |
ASX - By Stock
|
60
|
15K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Introducing Cynata - independent research coverage
|
|
$4us
|
60 |
15K |
5 |
10/08/17 |
10/08/17 |
ASX - By Stock
|
60
|
15K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Introducing Cynata - independent research coverage
|
|
$4us
|
60 |
15K |
4 |
09/08/17 |
09/08/17 |
ASX - By Stock
|
60
|
15K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
But does it really work in humans?
|
|
$4us
|
43 |
12K |
3 |
06/08/17 |
06/08/17 |
ASX - By Stock
|
43
|
12K
|
3
|
|
Charts
|
CYP |
Re:
KILIAN KELLY INTERVIEW
|
|
$4us
|
8 |
2.0K |
2 |
28/07/17 |
28/07/17 |
Charts
|
8
|
2.0K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Global Market For Cell Therapy Manufacturing 2017
|
|
$4us
|
13 |
3.2K |
3 |
23/07/17 |
23/07/17 |
ASX - By Stock
|
13
|
3.2K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Global Market For Cell Therapy Manufacturing 2017
|
|
$4us
|
13 |
3.2K |
8 |
23/07/17 |
23/07/17 |
ASX - By Stock
|
13
|
3.2K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Global Market For Cell Therapy Manufacturing 2017
|
|
$4us
|
13 |
3.2K |
2 |
22/07/17 |
22/07/17 |
ASX - By Stock
|
13
|
3.2K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Global Market For Cell Therapy Manufacturing 2017
|
|
$4us
|
13 |
3.2K |
4 |
22/07/17 |
22/07/17 |
ASX - By Stock
|
13
|
3.2K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
roll out the news
|
|
$4us
|
300 |
82K |
7 |
04/07/17 |
04/07/17 |
ASX - By Stock
|
300
|
82K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: CYP MSC Data in Asthma Model Published in Sceintific Journal
|
|
$4us
|
64 |
22K |
15 |
29/06/17 |
29/06/17 |
ASX - By Stock
|
64
|
22K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: CYP MSC Data in Asthma Model Published in Sceintific Journal
|
|
$4us
|
64 |
22K |
1 |
29/06/17 |
29/06/17 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Therapeutics GvHD Clinical Trial & Corporate Progress
|
|
$4us
|
49 |
15K |
0 |
27/06/17 |
27/06/17 |
ASX - By Stock
|
49
|
15K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Therapeutics GvHD Clinical Trial & Corporate Progress
|
|
$4us
|
49 |
15K |
6 |
27/06/17 |
27/06/17 |
ASX - By Stock
|
49
|
15K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: United States Patent for Core Cynata Technology
|
|
$4us
|
8 |
3.7K |
3 |
26/06/17 |
26/06/17 |
ASX - By Stock
|
8
|
3.7K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Files New Patent Application for Cymerus in Oncology
|
|
$4us
|
17 |
5.8K |
2 |
20/06/17 |
20/06/17 |
ASX - By Stock
|
17
|
5.8K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Van Leeuwenhoeck Institute Initiates CYP Research Coverage
|
|
$4us
|
12 |
5.0K |
9 |
07/06/17 |
07/06/17 |
ASX - By Stock
|
12
|
5.0K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
US road show about to kick off.. toot toot
|
|
$4us
|
98 |
26K |
3 |
30/05/17 |
30/05/17 |
ASX - By Stock
|
98
|
26K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
riken temcell
|
|
$4us
|
47 |
11K |
1 |
28/05/17 |
28/05/17 |
ASX - By Stock
|
47
|
11K
|
1
|
|
Charts
|
CYP |
Re:
CYP chart
|
|
$4us
|
1.9K |
594K |
2 |
25/05/17 |
25/05/17 |
Charts
|
1.9K
|
594K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
sale of the century
|
|
$4us
|
59 |
17K |
7 |
18/05/17 |
18/05/17 |
ASX - By Stock
|
59
|
17K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
sale of the century
|
|
$4us
|
59 |
17K |
10 |
18/05/17 |
18/05/17 |
ASX - By Stock
|
59
|
17K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
News: CYP Cynata Therapeutics seeks trading halt
|
|
$4us
|
128 |
44K |
4 |
17/05/17 |
17/05/17 |
ASX - By Stock
|
128
|
44K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Shaws Morning report Target $1.20
|
|
$4us
|
129 |
46K |
3 |
08/05/17 |
08/05/17 |
ASX - By Stock
|
129
|
46K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Shaws Morning report Target $1.20
|
|
$4us
|
129 |
46K |
5 |
08/05/17 |
08/05/17 |
ASX - By Stock
|
129
|
46K
|
5
|
|